Sanguine Engineers Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 43 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 9.85 M
- Revenue Growth 1.51%
- Profit Growth -8.91%
- Ebitda 1.00%
- Net Worth 8.87%
- Total Assets 9.91%
About Sanguine Engineers
Sanguine Engineers Private Limited (SEPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 1981 and has a history of 43 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹9.85 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashish Shah and Kanchan Shah serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U29199KA1981PTC004488
-
Company No.
004488
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Nov 1981
-
Date of AGM
13 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Sanguine Engineers?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Shah
|
Director | 16-Jul-2016 | Current |
|
Kanchan Shah
|
Director | 16-Jul-2016 | Current |
Financial Performance of Sanguine Engineers.
Sanguine Engineers Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.51% increase. The company also saw a slight decrease in profitability, with a 8.91% decrease in profit. The company's net worth moved up by a moderate rise of 8.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Engineers?
In 2019, Sanguine Engineers had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹9.85 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.95 Cr
- Central Bank Of India : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Mar 2012 | Canara Bank | ₹3.88 M | Satisfied |
| 27 Jul 2006 | Canara Bank | ₹5.60 M | Satisfied |
| 10 Apr 1987 | Central Bank Of India | ₹0.38 M | Satisfied |
How Many Employees Work at Sanguine Engineers?
Unlock and access historical data on people associated with Sanguine Engineers, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Engineers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Engineers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
